NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Devices · USD

908 Devices Inc. (MASS) Stock Analysis

908 Devices Inc. (MASS) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

MASS

$10.05

+$0.01 (+0.10%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MASS with… →

MASS Key Statistics

As of Sep 4, 2026
Trading
Open
$10.02
Previous Close
$10.04
Day's Range
9.87–10.12
52-Week Range
5.03–11.25
Volume
201.10K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.68
Valuation
Market Cap
$415.40M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
6.83
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.93
Financials (FY)
Revenue (FY)
$56.20M+17.70%
Net Income (FY)
$19.49M
Profit marginThe share of revenue left as profit after all costs and taxes.
−56.96%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
41.33M
1-Year Return
+82.73%
Dividend and dates
Earnings Date
November 10, 2026
Avg Volume
385.11K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

MASS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+91.43%
2025+138.64%
2024−80.39%
2023+47.24%
2022−70.55%
2021−54.57%
2020 (partial year)+16.22%

As of September 4, 2026.

MASS Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$56.20M$19.49M34.7%
2024$47.75M−$72.21M−151.2%
2023$50.23M−$36.40M−72.5%
2022$46.85M−$33.56M−71.6%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$56.20M$28.42M−$25.68M$19.49M34.7%
2024$47.75M$24.50M−$29.95M−$72.21M−151.2%
2023$50.23M$25.32M−$42.65M−$36.40M−72.5%
2022$46.85M$26.02M−$35.38M−$33.56M−71.6%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

MASS Valuation vs Medical Devices Median

Median of 151 stocks
MetricMASSMedical Devices medianvs median
P/S ratio6.832.98129% above
Profit margin−56.96%−1.69%55.3 pts below

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 13 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

908 Devices Inc. (MASS) carries a market capitalisation of $415.40M. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 172.

Over the past 52 weeks the price has ranged from $5.03 to $11.25. The most recent close on file for MASS is $10.05, dated September 4, 2026. That is +$0.01 (+0.10%) against the previous close. The latest close sits 100% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $56.20M. That is +17.70% against the prior fiscal year, when revenue was $47.75M. The same year closed with net income of $19.49M. The reported profit margin is −56.96%. That is 55.3 percentage points below the Medical Devices median of −1.69%. Trailing earnings per share are −0.93.

Across the 4 fiscal years on file, revenue moves from $46.85M in 2022 to $56.20M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The price-to-sales ratio is 6.83. On price-to-sales that is 129.42% above the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The trailing one-year price return is +82.73%. Across 5 years the annualized return works out at −23.80%. Beta against the wider market is reported at 0.68. Annualized volatility over the trailing 5 years is 94.82%.

Growth & Income

No dividend is on file for MASS.

Across the complete calendar years on file, 2025 returned +138.64% and 2024 returned −80.39%. Of the 5 complete calendar years on file, 2 finished higher. 2026 is still running; the price is +91.43% year to date.

Peer Comparison

908 Devices Inc. (MASS) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
908 Devices Inc. MASS $415.40M —
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. 908 Devices Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$187.45B

 MDT

Medtronic plc.

$120.46B

 SYK

Stryker Corporation

$116.27B

 BSX

Boston Scientific Corporation

$69.27B

 EW

Edwards Lifesciences Corporation

$51.82B

 DXCM

DexCom, Inc.

$33.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About 908 Devices Inc.

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample. It operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of Americas. The company was incorporated in 2012 and is headquartered in Burlington, Massachusetts.

Visit website →